Tag: Alzheimer’s
Lifestyle Interventions Improve Cognition for At-Risk Older Adults
Significantly greater benefit on global cognition seen for structured versus self-guided intervention over two years
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
GLP-1 receptor agonist use linked to lower risk for overall dementia, Alzheimer disease, nonvascular dementia compared with metformin
Greater Neighborhood Disadvantage Tied to Inflammatory, Alzheimer Disease Biomarkers
Cross-sectional association seen for greater neighborhood disadvantage with CSF chitinase-3-like protein 1 and tau
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup
Late-Life Mood Disorders May Indicate Predisposition to Dementia
Participants with LLMDs more likely to be tau PET- and amyloid β PET-positive compared with healthy controls
Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors
In landmark analyses, lower risk did not persist beyond five years of survival
Dementia Caregivers Have Modifiable Risk Factors Increasing Their Own Risk
Findings seen particularly among younger dementia caregivers under 45 years of age
Doctors’ Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
About half of physicians would consider euthanasia as a good or very good option in a scenario of advanced cancer or Alzheimer disease
Epilepsy More Common With Frontotemporal Dementia
Findings compared to people with Alzheimer disease and healthy controls
Higher MIND Diet Adherence Cuts Risk for Alzheimer Disease and Related Dementias
Relationship varied among five examined racial and ethnic groups
